F
Feature stories - WHO
Who
RSSen

Feature stories - WHO

Information
Website
Who
Followers
Following

Latest posts

website-logo

Improving quality of medicines for maternal health: what can parliamentarians do?

Feature stories - WHO

A substantial proportion of medicines for maternal health care are substandard quality, including those used to manage postpartum haemorrhage (PPH), the leading cause of maternal death. In many countries, particularly in low- and middle-income countries, healthcare providers cannot trust the effecti

website-logo

What's in a vaccine?

Feature stories - WHO

Learn more about vaccines – from how they work to how they’re made – in WHO’s Learn more about vaccines – from how they work to how they’re made – in WHO’s  Vaccines Explained series Vaccines are made up of carefully selected components that work together to protect against disease.  Each vaccine co

website-logo

Finding a path to language justice in sexual and reproductive health and rights

Feature stories - WHO

English language dominates the global public health space. This is an often-neglected weakness in the goal to achieve health for everyone, everywhere. Language justice is an approach to shifting this monopoly, to be more inclusive of different language speakers. Shining a spotlight on sexual and re

website-logo

Vaccine efficacy, effectiveness and protection

Feature stories - WHO

This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series. Vaccines are safe, effective and life-saving. Before approval by

website-logo

Ensuring vaccine safety

Feature stories - WHO

This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series. How vaccines are tested and monitored  Most vaccines have been in

website-logo

How to talk about vaccines

Feature stories - WHO

This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series. Vaccines are supported by decades of medical research. They work

website-logo

How are vaccines developed and produced?

Feature stories - WHO

This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series. How are vaccines developed and produced?  Developing a vaccine st

website-logo

How do vaccines work?

Feature stories - WHO

This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.\r\n Germs are all around us, both in our environment and in our b

website-logo

Strengthened regulation of tobacco-free venues at FIFA World Cup Qatar 2022™

Feature stories - WHO

Footballs won’t be the only things kicked in Qatar at the FIFA World Cup Qatar 2022™. Tobacco and e-cigarettes will also be kicked out of Doha’s eight stadiums, ensuring fans can enjoy smoke-free air while sitting in their seats watching\r\n world football’s biggest event. \r\n Implementing tobac

website-logo

The Novavax vaccine against COVID-19: What you need to know

Feature stories - WHO

This webpage was updated on 28 September 2022 to ensure consistency of formatting. The Technical Advisory Group for Emergency Use Listing listed Nuvaxovid (NVX-CoV2373) vaccine against COVID-19 and Covovax (NVX-CoV2373) vaccine against COVID-19 for emergency use on 20 December 2021 and 17 December 2

website-logo

Nothing for us, without us: new film series on people living with noncommunicable diseases and mental health conditions

Feature stories - WHO

Helena, a paediatrician and mother, living in Sheffield in the United Kingdom of Great Britain and Northern Ireland, was already living with multiple disabilities caused by an auto-inflammatory disease when she was diagnosed with cancer in 2009. “I went from being a very active, very dynamic paedia

website-logo

The Valneva VLA2001 COVID-19 vaccine: What you need to know

Feature stories - WHO

This webpage was published on 18 August 2022. The Valneva vaccine is a purified, inactivated, and adjuvanted whole virus SARS-CoV-2 vaccine. The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has issued interim policy recommendations for the use of the Valneva (VLA2001) vaccine. This

website-logo

The Moderna COVID-19 (mRNA-1273) vaccine: what you need to know

Feature stories - WHO

Updated 18 August 2022, to adhere to the latest SAGE recommendations. The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has issued updated interim recommendations for the use of the Moderna COVID-19 (mRNA-1273) vaccine against COVID-19. This article provides a summary of those\r\n

website-logo

The Pfizer BioNTech (BNT162b2) COVID-19 vaccine: What you need to know

Feature stories - WHO

Updated 18 August 2022, to reflect the latest SAGE recommendations The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has issued interim recommendations for the use of the Pfizer BioNTech (BNT162b2) vaccine against COVID-19. This article provides a summary of those interim recommenda

website-logo

The Oxford/AstraZeneca (ChAdOx1-S [recombinant] vaccine) COVID-19 vaccine: what you need to know

Feature stories - WHO

Updated on 13 June 2022 to ensure consistency of formatting. The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has issued interim recommendations for use of the Oxford/AstraZeneca COVID-19 vaccine (ChAdOx1-S [recombinant] vaccine).  You may access the guidance document here.  Who ca

website-logo

The Sinopharm COVID-19 vaccine: What you need to know

Feature stories - WHO

Updated on 10 June 2022, pursuant to revised interim recommendations. The WHO Strategic Advisory Group of Experts (SAGE) has issued interim recommendations for the use of the Sinopharm vaccine against COVID-19. This article provides a summary of those interim recommendations; you may access the full

website-logo

The Sinovac-CoronaVac COVID-19 vaccine: What you need to know

Feature stories - WHO

Updated on 10 June 2022 pursuant to revised interim recommendations. The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has issued updated interim policy recommendations for the use of the Sinovac-CoronaVac vaccine against COVID-19. This article provides a summary of those interim re

website-logo

The CanSino Biologics Ad5-nCoV-S [recombinant] COVID-19 vaccine: What you need to know

Feature stories - WHO

The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has\r\n issued updated interim policy recommendations for the use of the Ad5-nCoV-S recombinant (Ad5-nCoV) vaccine against COVID-19. This article provides a summary of those interim recommendations; you may access the full guidance d

website-logo

The Bharat Biotech BBV152 COVAXIN vaccine against COVID-19: What you need to know

Feature stories - WHO

Updated on 10 June 2022, pursuant to revised interim recommendations. On 3 November 2021, the Technical Advisory Group for Emergency Use Listing listed the Bharat Biotech BBV152 COVAXIN vaccine against COVID-19 for emergency use. The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has

website-logo

The Janssen Ad26.COV2.S COVID-19 vaccine: What you need to know

Feature stories - WHO

Updated 6 June 2022, pursuant to updated interim recommendations  The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has\r\n issued interim recommendations for the use of the Janssen Ad26.COV2.S COVID-19 vaccine against COVID-19.  Here is what you need to know. This article provides

website-logo

Chile: where action on hypertension is saving lives

Feature stories - WHO

In Chile, more people die from cardiovascular disease than from any other cause. More than a quarter of all deaths every year – around 30 000 in total – are due to the disease. Hypertension – also known as high blood pressure – is a serious medical condition and a key risk factor for cardiovascula

website-logo

Q&A on malaria elimination in China

Feature stories - WHO

What is a WHO certification of malaria elimination? Certification of malaria elimination is the official recognition by WHO of a country’s malaria-free status. WHO grants this certification when a country has demonstrated, with rigorous, credible evidence, that the chain of local transmission of\r\n

website-logo

PAHO paving the way for COVID-19 vaccination in the Americas

Feature stories - WHO

Following decades of positive experience in forecasting and procuring vaccines and supplies from the Revolving Fund, The Pan American Health Organization (PAHO) aligned with WHO and its partners to implement the COVAX Facility in the Americas. The COVID-19\r\n pandemic represented an unprecedente

website-logo

Side Effects of COVID-19 Vaccines

Feature stories - WHO

This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.   COVID-19 vaccines are safe, and getting vaccinated will help pro

website-logo

Getting the COVID-19 Vaccine

Feature stories - WHO

This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.   Vaccines are a critical tool in the battle against COVID-19, and